ClinicalTrials.Veeva

Menu

Prevalence of Chronic Obstructive Pulmonary Disease in the Portuguese Population (EpiCOPDpt)

S

Sociedade Portuguesa de Pneumologia

Status

Not yet enrolling

Conditions

Chronic Obstructive Pulmonary Disease

Treatments

Diagnostic Test: Spirometry

Study type

Observational

Funder types

Other

Identifiers

NCT06523257
2023_EO_EPICOPDPT

Details and patient eligibility

About

The EpiCOPDpt Study (Prevalence of Chronic Obstructive Pulmonary Disease in the Portuguese Population) primary objective is to estimate the prevalence of Chronic Obstructive Pulmonary Disease (COPD) in the Portuguese population aged 20 and over. It is a cross-sectional study of a representative sample of the Portuguese population aged 20 and over, using standardised post-bronchodilator spirometry. Questionnaires will be applied to collect sociodemographic, economic, clinical, and therapeutic data.

Enrollment

8,589 estimated patients

Sex

All

Ages

20+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male and female subjects aged 20 years and over, with permanent or temporary residence for at least one year in the national territory;
  • Written informed consent for study participation.

Exclusion criteria

  • Any condition that makes it impossible to perform spirometry, in accordance with standards of the joint American Thoracic Society/European Respiratory Society, and as described in the "Contraindications for spirometry testing" section of the Study Procedures Manual;
  • Any condition that makes it impossible to perform the bronchodilation, as described in the "Contraindications for bronchodilation" section of the Study Procedures Manual;
  • Severe cognitive disability that may interfere with the person's capability to participate in the study.

Trial contacts and locations

0

Loading...

Central trial contact

Ana Barros, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems